Literature DB >> 22207895

The c-Rel Transcription Factor in Development and Disease.

Thomas D Gilmore1, Steve Gerondakis.   

Abstract

c-Rel is a member of the nuclear factor κB (NF-κB) transcription factor family. Unlike other NF-κB proteins that are expressed in a variety of cell types, high levels of c-Rel expression are found primarily in B and T cells, with many c-Rel target genes involved in lymphoid cell growth and survival. In addition to c-Rel playing a major role in mammalian B and T cell function, the human c-rel gene (REL) is a susceptibility locus for certain autoimmune diseases such as arthritis, psoriasis, and celiac disease. The REL locus is also frequently altered (amplified, mutated, rearranged), and expression of REL is increased in a variety of B and T cell malignancies and, to a lesser extent, in other cancer types. Thus, agents that modulate REL activity may have therapeutic benefits for certain human cancers and chronic inflammatory diseases.

Entities:  

Keywords:  B cells; NF-κB; REL; T cells; arthritis; c-Rel; cancer; signal transduction

Year:  2011        PMID: 22207895      PMCID: PMC3218406          DOI: 10.1177/1947601911421925

Source DB:  PubMed          Journal:  Genes Cancer        ISSN: 1947-6019


  228 in total

Review 1.  Lymphoid malignancies: the dark side of B-cell differentiation.

Authors:  A L Shaffer; Andreas Rosenwald; Louis M Staudt
Journal:  Nat Rev Immunol       Date:  2002-12       Impact factor: 53.106

2.  c-Rel is required for chromatin remodeling across the IL-2 gene promoter.

Authors:  Sudha Rao; Steve Gerondakis; Donna Woltring; M Frances Shannon
Journal:  J Immunol       Date:  2003-04-01       Impact factor: 5.422

Review 3.  Roles of the NF-kappaB pathway in lymphocyte development and function.

Authors:  Steve Gerondakis; Ulrich Siebenlist
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-12-23       Impact factor: 10.005

4.  Oncogenic transformation by vrel requires an amino-terminal activation domain.

Authors:  J Kamens; P Richardson; G Mosialos; R Brent; T Gilmore
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

5.  Interaction of the v-Rel oncoprotein with cellular transcription factor Sp1.

Authors:  S Sif; T D Gilmore
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

6.  Differential expression patterns of c-REL protein in classic and nodular lymphocyte predominant Hodgkin lymphoma.

Authors:  Qianxun Xiao; Ning Shen; Cyrus V Hedvat; Craig H Moskowitz; Louis K Sussman; Daniel A Filippa; Andrew D Zelenetz; Jane Houldsworth; Raju S K Chaganti; Julie Teruya-Feldstein
Journal:  Appl Immunohistochem Mol Morphol       Date:  2004-09

7.  NF-kappaB is required for CD38-mediated induction of C(gamma)1 germline transcripts in murine B lymphocytes.

Authors:  Hiroaki Kaku; Keisuke Horikawa; Yuichi Obata; Ichiro Kato; Hiroshi Okamoto; Nobuo Sakaguchi; Steve Gerondakis; Kiyoshi Takatsu
Journal:  Int Immunol       Date:  2002-09       Impact factor: 4.823

8.  The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma.

Authors:  Kerry J Savage; Stefano Monti; Jeffery L Kutok; Giorgio Cattoretti; Donna Neuberg; Laurence De Leval; Paul Kurtin; Paola Dal Cin; Christine Ladd; Friedrich Feuerhake; Ricardo C T Aguiar; Sigui Li; Gilles Salles; Francoise Berger; Wen Jing; Geraldine S Pinkus; Thomas Habermann; Riccardo Dalla-Favera; Nancy Lee Harris; Jon C Aster; Todd R Golub; Margaret A Shipp
Journal:  Blood       Date:  2003-08-21       Impact factor: 22.113

9.  REL proto-oncogene is frequently amplified in extranodal diffuse large cell lymphoma.

Authors:  J Houldsworth; S Mathew; P H Rao; K Dyomina; D C Louie; N Parsa; K Offit; R S Chaganti
Journal:  Blood       Date:  1996-01-01       Impact factor: 22.113

10.  Genome-wide analyses of recombination prone regions predict role of DNA structural motif in recombination.

Authors:  Prithvi Mani; Vinod Kumar Yadav; Swapan Kumar Das; Shantanu Chowdhury
Journal:  PLoS One       Date:  2009-02-09       Impact factor: 3.240

View more
  44 in total

1.  Loss of c-REL but not NF-κB2 prevents autoimmune disease driven by FasL mutation.

Authors:  L A O'Reilly; P Hughes; A Lin; P Waring; U Siebenlist; R Jain; D H D Gray; S Gerondakis; A Strasser
Journal:  Cell Death Differ       Date:  2014-10-31       Impact factor: 15.828

2.  Single-Cell Genomics Unveils Critical Regulators of Th17 Cell Pathogenicity.

Authors:  Jellert T Gaublomme; Nir Yosef; Youjin Lee; Rona S Gertner; Li V Yang; Chuan Wu; Pier Paolo Pandolfi; Tak Mak; Rahul Satija; Alex K Shalek; Vijay K Kuchroo; Hongkun Park; Aviv Regev
Journal:  Cell       Date:  2015-11-19       Impact factor: 41.582

3.  Combined immunodeficiency in a patient with c-Rel deficiency.

Authors:  Sarah Beaussant-Cohen; Faris Jaber; Michel J Massaad; Sabrina Weeks; Jennifer Jones; Mohammed F Alosaimi; Jacqueline Wallace; Waleed Al-Herz; Raif S Geha; Janet Chou
Journal:  J Allergy Clin Immunol       Date:  2019-05-16       Impact factor: 10.793

4.  Exclusivity and Compensation in NFκB Dimer Distributions and IκB Inhibition.

Authors:  Kristen M Ramsey; Wei Chen; James D Marion; Simon Bergqvist; Elizabeth A Komives
Journal:  Biochemistry       Date:  2019-05-14       Impact factor: 3.162

5.  c-Rel Regulates Inscuteable Gene Expression during Mouse Embryonic Stem Cell Differentiation.

Authors:  Riki Ishibashi; Satoshi Kozuki; Sachiko Kamakura; Hideki Sumimoto; Fumiko Toyoshima
Journal:  J Biol Chem       Date:  2015-12-22       Impact factor: 5.157

Review 6.  Genetics of primary sclerosing cholangitis and pathophysiological implications.

Authors:  Xiaojun Jiang; Tom H Karlsen
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-03-15       Impact factor: 46.802

7.  Heparanase promotes myeloma stemness and in vivo tumorigenesis.

Authors:  Kaushlendra Tripathi; Vishnu C Ramani; Shyam K Bandari; Rada Amin; Elizabeth E Brown; Joseph P Ritchie; Mark D Stewart; Ralph D Sanderson
Journal:  Matrix Biol       Date:  2019-12-05       Impact factor: 11.583

8.  c-Rel gain in B cells drives germinal center reactions and autoantibody production.

Authors:  Maike Kober-Hasslacher; Hyunju Oh-Strauß; Dilip Kumar; Valeria Soberon; Carina Diehl; Maciej Lech; Thomas Engleitner; Eslam Katab; Vanesa Fernández-Sáiz; Guido Piontek; Hongwei Li; Björn Menze; Christoph Ziegenhain; Wolfgang Enard; Roland Rad; Jan P Böttcher; Hans-Joachim Anders; Martina Rudelius; Marc Schmidt-Supprian
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

9.  Activation of the transcriptional function of the NF-κB protein c-Rel by O-GlcNAc glycosylation.

Authors:  Parameswaran Ramakrishnan; Peter M Clark; Daniel E Mason; Eric C Peters; Linda C Hsieh-Wilson; David Baltimore
Journal:  Sci Signal       Date:  2013-08-27       Impact factor: 8.192

10.  Global landscape of mouse and human cytokine transcriptional regulation.

Authors:  Sebastian Carrasco Pro; Alvaro Dafonte Imedio; Clarissa Stephanie Santoso; Kok Ann Gan; Jared Allan Sewell; Melissa Martinez; Rebecca Sereda; Shivani Mehta; Juan Ignacio Fuxman Bass
Journal:  Nucleic Acids Res       Date:  2018-10-12       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.